Mounjaro pre-filled pen on a dark background

Registered medicine

Tirzepatide · GIP/GLP-1

Mounjaro

Registered medicine (EMA)
Studied in clinical trials*
Doses from 2.5mg to 15mg
Part of a program with lifestyle coaching and guidance

Program from

€269,54/month

Cancel monthly. If you decide not to start after your consultation, you get your money back right away.

Start the questionnaire

Administration

Weekly injection

Dosage

2.5mg – 15mg

Active substance

Tirzepatide

Manufacturer

Eli Lilly

Mounjaro is registered in Europe for weight management in overweight and obesity, alongside the treatment of type 2 diabetes. The active substance is tirzepatide.

How it works

How tirzepatide works in your body.

Dual action

Tirzepatide mimics two gut hormones, GIP and GLP-1. That combination curbs your appetite along two routes at once.

Fuller for longer

Your stomach empties more slowly, so you stay full longer after a meal and reach for snacks less often.

Studied in trials

The efficacy and safety of tirzepatide were studied in large clinical trials over 72 weeks.*

Building up gently

Your dose grows with you.

Starting low is not a detour but clinical guideline: your body adjusts and side effects stay manageable. You and your doctor set the pace together.

2.5 mg

Weeks 1–4 · adjusting

Your body builds tolerance.

5 mg

From week 5 · maintenance

The steady dose for many clients.

7.5 – 10 mg

Optional

Step by step, when there is reason to.

12.5 – 15 mg

Optional

Only if a higher dose is needed.

What your medication costs per dose is shown once you have signed up. You get the full overview before you pay anything.

See the full price overview

Already in treatment

Already with another clinic?

In three steps, compare what you pay each month now with what it would be with us. You see the difference straight away.

More than medication

Medication is one part of your program.

Medical intake and oversight, a doctor assesses your situation and follows your progress
Online lifestyle program covering nutrition, sleep, stress and exercise
Personal treatment plan with dosing tailored to you
Discreet home delivery, cooled and fast

See the full program

Compare

Still deciding between treatments?

During the online consultation the doctor advises what suits you best.

Semaglutide

Treatment with Wegovy

Dosage0.25mg – 2.4mg

Program from€ 200,99 /mo

View Wegovy

Semaglutide

Treatment with Ozempic

Dosage0.25mg – 2mg

Program from€ 199,99 /mo

View Ozempic

This pageTirzepatide

Treatment with Mounjaro

Dosage2.5mg – 15mg

Program from€ 269,54 /mo

Administrationweekly

FAQ

Frequently asked questions about Mounjaro

A BIG-registered doctor reviews your questionnaire and medical situation. In general you qualify with a BMI of 30 or higher, or 27 and up combined with a weight-related health condition. Not sure? Filling in the questionnaire is free of obligation.

Mounjaro contains tirzepatide, which mimics two hormones (GIP and GLP-1), whereas semaglutide mimics one. In clinical trials, participants on tirzepatide lost more weight on average. Which treatment suits you depends on your situation; the doctor advises during the consultation.

Everything that belongs to your program: the medication, doctor consultations, personal coaching, the lifestyle program and cooled shipping. The amount depends on your dose and you can cancel monthly.

The most common side effects are nausea, constipation and diarrhea, especially in the first weeks and around a dose increase. They usually fade as your body adjusts. That is why we build up the dose gently, and you can always reach your doctor if symptoms persist.

That differs per person. The clinical trials of tirzepatide ran for 72 weeks, and in practice many clients work on their goal for 6 to 12 months or longer. You evaluate regularly with your doctor whether continuing makes sense.

See all frequently asked questions

Wondering whether treatment suits you?

Fill in the questionnaire, it takes about 10 minutes. A doctor reviews your situation and advises whether the treatment suits you.

Start the questionnaireNo obligation · cancel monthly

* Refers to published clinical trials of tirzepatide over 72 weeks (SURMOUNT-1). Results vary per person and are no guarantee. Mounjaro is a registered trademark of Eli Lilly and Company. This page is intended to inform, not to promote medicines. Read the package leaflet before use. A doctor always assesses first whether treatment is medically appropriate.

Blog about medical weight loss

Read our articles about medical weight loss, lifestyle, nutrition, medication, obesity, exercise and healthy living.

Wegovy pil goedgekeurd in Europa: de eerste GLP-1 pil voor gewichtsbeheersing

De Europese Commissie heeft de Wegovy pil goedgekeurd als eerste GLP-1 pil voor gewichtsbeheersing in de EU. Wat is er precies goedgekeurd en wanneer komt de pil naar Nederland?

Orforglipron (Foundayo): wat de GLP-1-pil kan en wanneer hij hier is

De FDA keurde orforglipron op 1 april 2026 goed als Foundayo, de eerste GLP-1-pil zonder eet- of drinkvoorschriften. Wat de ATTAIN-studies laten zien, welke bijwerkingen erbij horen en wanneer het middel in Nederland te verwachten is.

Ontsteking en obesitas: waar start de vicieuze cirkel?

Een diepgaande blik op de complexe relatie tussen obesitas en chronische ontsteking, hoe ze elkaar versterken, en hoe leefstijl en nieuwe behandelingen zoals GLP-1 medicatie deze cirkel kunnen doorbreken.